A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 childhood cohort (AB3C) study

Members: Carmen Charlton, Graham Tipples

6 April 2023

A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 childhood cohort (AB3C) study.
Doucette EJ, Gray J, Fonseca K, Charlton C, Kanji JN, Tipples G, Kuhn S, Dunn J, Sayers P, Symonds N, Wu G, Freedman SB, Kellner JD.
PLoS One. 2023 Apr 6;18(4):e0284046. doi: 10.1371/journal.pone.0284046. eCollection 2023.
PMID: 37023007